Empagliflozin restores neutropenia and neutrophil dysfunction in a young patient with severe congenital neutropenia type 4

J Allergy Clin Immunol Pract. 2023 Jan;11(1):344-346.e1. doi: 10.1016/j.jaip.2022.10.019. Epub 2022 Oct 26.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Humans
  • Mutation
  • Neutropenia* / congenital
  • Neutropenia* / drug therapy
  • Neutrophils*

Substances

  • empagliflozin

Supplementary concepts

  • Neutropenia, Severe Congenital, Autosomal Recessive 3
  • Neutropenia, Severe Congenital, Autosomal Recessive 4